162 related articles for article (PubMed ID: 17675942)
41. Primary carcinomas of the thymus gland.
Ritter JH; Wick MR
Semin Diagn Pathol; 1999 Feb; 16(1):18-31. PubMed ID: 10355651
[TBL] [Abstract][Full Text] [Related]
42. A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size, and tumor markers.
Kimura H; Iwai N; Ando S; Kakizawa K; Yamamoto N; Hoshino H; Anayama T
Ann Thorac Surg; 2003 Jun; 75(6):1734-9. PubMed ID: 12822608
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
[TBL] [Abstract][Full Text] [Related]
44. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 1998 Oct; 22(10):1215-21. PubMed ID: 9777983
[TBL] [Abstract][Full Text] [Related]
45. Large-cell carcinoma of the lung: a diagnostic category redefined by immunohistochemistry and genomics.
Sholl LM
Curr Opin Pulm Med; 2014 Jul; 20(4):324-31. PubMed ID: 24811836
[TBL] [Abstract][Full Text] [Related]
46. Epithelial tumors of the lung.
Gould VE; Warren WH
Chest Surg Clin N Am; 2000 Nov; 10(4):709-28. PubMed ID: 11091921
[TBL] [Abstract][Full Text] [Related]
47. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
Kayser G
Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246
[TBL] [Abstract][Full Text] [Related]
48. [Pathology of lung neuroendocrine tumors].
Fillinger J
Magy Onkol; 2018 Jul; 62(2):83-89. PubMed ID: 30027935
[TBL] [Abstract][Full Text] [Related]
49. The expression of trophoblastic cell markers by lung carcinomas.
Boucher LD; Yoneda K
Hum Pathol; 1995 Nov; 26(11):1201-6. PubMed ID: 7590693
[TBL] [Abstract][Full Text] [Related]
50. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
[TBL] [Abstract][Full Text] [Related]
51. Large cell carcinoma of the lung: a tumor in search of an author. A clinically oriented critical reappraisal.
Pelosi G; Barbareschi M; Cavazza A; Graziano P; Rossi G; Papotti M
Lung Cancer; 2015 Mar; 87(3):226-31. PubMed ID: 25620799
[TBL] [Abstract][Full Text] [Related]
52. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.
Sturm N; Lantuéjoul S; Laverrière MH; Papotti M; Brichon PY; Brambilla C; Brambilla E
Hum Pathol; 2001 Sep; 32(9):918-25. PubMed ID: 11567220
[TBL] [Abstract][Full Text] [Related]
53. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
Findeis-Hosey JJ; Xu H
Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
[TBL] [Abstract][Full Text] [Related]
54. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
[TBL] [Abstract][Full Text] [Related]
55. [Evaluation of the "N" factor in nonsmall cell lung cancer. Correlation between computerized tomography and pathologic anatomy].
Pirronti T; Macis G; Sallustio G; Minordi LM; Granone P; Vecchio FM; Marano P
Radiol Med; 2000 May; 99(5):340-6. PubMed ID: 10938702
[TBL] [Abstract][Full Text] [Related]
56. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
Kadivar M; Boozari B
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
[TBL] [Abstract][Full Text] [Related]
57. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
58. [Risk factors influencing lymph nodes metastasis in lung cancer with stage I, II or IIIA].
Hirayama T; Kaneda Y; Nawata S; Tanaka S; Esato K
Nihon Kyobu Geka Gakkai Zasshi; 1990 Oct; 38(10):2049-55. PubMed ID: 2176232
[TBL] [Abstract][Full Text] [Related]
59. [2014 classification of lung carcinomas: latest entities and clinical implications. Case 2: Basaloid carcinoma].
Vignaud JM
Ann Pathol; 2013 Oct; 33(5):311-3. PubMed ID: 24238240
[No Abstract] [Full Text] [Related]
60. [Large cell carcinoma, lymphoepithelioma-like carcinoma, NUT carcinoma].
Copin MC
Ann Pathol; 2016 Jan; 36(1):24-33. PubMed ID: 26739900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
